
Due to the COVID-19 pandemic, the global DHA from Algae market size is estimated to be worth US$ 473.80 million in 2022 and is forecast to a readjusted size of US$ 969.91 million by 2028 with a CAGR of 12.68% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, DHA Powder accounting for 35.86% of the DHA from Algae global market in 2021, is projected to value US$ 250.02 million by 2028, growing at a revised 7.51% CAGR from 2022 to 2028. While Infant Formula segment is altered to a 14.25% CAGR throughout this forecast period.
North America DHA from Algae market size was US$ 164.70 million in 2021, while Europe was US$ 89.97 million. The proportion of the North America was 40.56% in 2021, while Europe's percentage was 22.16%, and it is predicted that Europe market share will reach 19.41% in 2028, trailing a CAGR of 10.29% through the analysis period.
The global major manufacturers of DHA from Algae include DSM, Roquette, Corbion, Huison, Runke, ADM, Mara Renewables, Cabio, Solutex, Kingdomway, Fermentalg, JC Biotech, Keyuan, Bioplus Life Sciences, Fuxing, etc. In terms of revenue, the global three largest players hold a 62.30% market share of DHA from Algae in 2021.
This report focuses on DHA from Algae volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall DHA from Algae market size by analysing historical data and future prospect.
Global DHA from Algae Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global DHA from Algae Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. By Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
By Company
DSM
Fermentalg
JC Biotech
Bioplus Life Sciences
Roquette
ADM
Runke
Fuxing
Solutex
Mara Renewables
Kingdomway
Keyuan
Huison
Cabio
Corbion
Segment by Type
DHA Powder
DHA Oil
Segment by Application
Infant Formula
Nutritional Supplements
Food & Beverage
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Australia
New Zealand
India
Others
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of Latin America
Middle East and Africa
Saudi Arabia
UAE
Turkey
Rest of Middle East and Africa
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 DHA FROM ALGAE MARKET OVERVIEW 1
1.1 PRODUCT OVERVIEW AND SCOPE OF DHA FROM ALGAE 1
1.2 DHA FROM ALGAE SEGMENT BY TYPE 1
1.2.1 GLOBAL DHA FROM ALGAE SALES GROWTH RATE COMPARISON BY TYPE (2022-2028) 2
1.2.2 DHA POWDER 3
1.2.3 DHA OIL 4
1.3 DHA FROM ALGAE SEGMENT BY APPLICATION 4
1.3.1 GLOBAL DHA FROM ALGAE SALES COMPARISON BY APPLICATION (2022-2028) 4
1.3.2 INFANT FORMULA 5
1.3.3 NUTRITIONAL SUPPLEMENTS 7
1.3.4 FOOD & BEVERAGE 8
1.3.5 OTHERS 9
1.4 GLOBAL DHA FROM ALGAE MARKET SIZE ESTIMATES AND FORECASTS 9
1.4.1 GLOBAL DHA FROM ALGAE REVENUE 2017-2028 9
1.4.2 GLOBAL DHA FROM ALGAE SALES 2017-2028 11
1.4.3 DHA FROM ALGAE MARKET SIZE BY REGION: 2017 VERSUS 2021 VERSUS 2028 11
2 DHA FROM ALGAE MARKET COMPETITION BY MANUFACTURERS 12
2.1 GLOBAL DHA FROM ALGAE SALES MARKET SHARE BY MANUFACTURERS (2017-2022) 12
2.2 GLOBAL DHA FROM ALGAE REVENUE MARKET SHARE BY MANUFACTURERS (2017-2022) 14
2.3 GLOBAL DHA FROM ALGAE AVERAGE PRICE BY MANUFACTURERS (2017-2022) 15
2.4 MANUFACTURERS DHA FROM ALGAE HEADQUARTERS, AREA SERVED, PRODUCT TYPE 16
2.5 DHA FROM ALGAE MARKET COMPETITIVE SITUATION AND TRENDS 17
2.5.1 DHA FROM ALGAE MARKET CONCENTRATION RATE 17
2.5.2 THE GLOBAL 3 AND 5 LARGEST DHA FROM ALGAE PLAYERS MARKET SHARE BY REVENUE 18
2.5.3 GLOBAL DHA FROM ALGAE MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) 19
2.6 MANUFACTURERS MERGERS & ACQUISITIONS, EXPANSION PLANS 19
2.7 DHA FROM ALGAE MARKET COMPETITION BY MANUFACTURERS IN APAC REGION 24
2.7.1 APAC DHA FROM ALGAE SALES MARKET SHARE BY MANUFACTURERS (2017-2022) 24
2.7.2 APAC DHA FROM ALGAE REVENUE MARKET SHARE BY MANUFACTURERS (2017-2022) 25
2.8 DHA FROM ALGAE MARKET COMPETITION BY MANUFACTURERS IN NORTH AMERICA REGION 26
2.8.1 NORTH AMERICA DHA FROM ALGAE SALES MARKET SHARE BY MANUFACTURERS (2017-2022) 26
2.8.2 NORTH AMERICA DHA FROM ALGAE REVENUE MARKET SHARE BY MANUFACTURERS (2017-2022) 27
3 DHA FROM ALGAE RETROSPECTIVE MARKET SCENARIO BY REGION 29
3.1 GLOBAL DHA FROM ALGAE RETROSPECTIVE MARKET SCENARIO IN SALES BY REGION: 2017-2022 29
3.2 GLOBAL DHA FROM ALGAE RETROSPECTIVE MARKET SCENARIO IN REVENUE BY REGION: 2017-2022 29
3.3 NORTH AMERICA DHA FROM ALGAE MARKET FACTS & FIGURES BY COUNTRY 30
3.3.1 NORTH AMERICA DHA FROM ALGAE SALES BY COUNTRY 30
3.3.2 NORTH AMERICA DHA FROM ALGAE REVENUE BY COUNTRY 31
3.3.3 UNITED STATES 32
3.3.4 CANADA 32
3.4 EUROPE DHA FROM ALGAE MARKET FACTS & FIGURES BY COUNTRY 33
3.4.1 EUROPE DHA FROM ALGAE SALES BY COUNTRY 33
3.4.2 EUROPE DHA FROM ALGAE REVENUE BY COUNTRY 33
3.4.3 GERMANY 34
3.4.4 FRANCE 35
3.4.5 U.K. 35
3.4.6 RUSSIA 36
3.4.7 ITALY 36
3.5 ASIA PACIFIC DHA FROM ALGAE MARKET FACTS & FIGURES BY REGION 37
3.5.1 ASIA PACIFIC DHA FROM ALGAE SALES BY REGION 37
3.5.2 ASIA PACIFIC DHA FROM ALGAE REVENUE BY REGION 37
3.5.3 CHINA 38
3.5.4 JAPAN 39
3.5.5 SOUTH KOREA 39
3.5.6 AUSTRALIA 40
3.5.7 NEW ZEALAND 40
3.5.8 INDIA 41
3.6 LATIN AMERICA DHA FROM ALGAE MARKET FACTS & FIGURES BY COUNTRY 41
3.6.1 LATIN AMERICA DHA FROM ALGAE SALES BY COUNTRY 41
3.6.2 LATIN AMERICA DHA FROM ALGAE REVENUE BY COUNTRY 42
3.6.3 BRAZIL 43
3.6.4 MEXICO 43
3.6.5 ARGENTINA 44
3.6.6 COLOMBIA 44
3.7 MIDDLE EAST AND AFRICA DHA FROM ALGAE MARKET FACTS & FIGURES BY COUNTRY 45
3.7.1 MIDDLE EAST AND AFRICA DHA FROM ALGAE SALES BY COUNTRY 45
3.7.2 MIDDLE EAST AND AFRICA DHA FROM ALGAE REVENUE BY COUNTRY 45
3.7.3 TURKEY 46
3.7.4 SAUDI ARABIA 47
3.7.5 UAE 47
4 DHA FROM ALGAE HISTORIC MARKET ANALYSIS BY TYPE 48
4.1 GLOBAL DHA FROM ALGAE SALES MARKET SHARE BY TYPE (2017-2022) 48
4.2 GLOBAL DHA FROM ALGAE REVENUE MARKET SHARE BY TYPE (2017-2022) 49
4.3 GLOBAL DHA FROM ALGAE PRICE BY TYPE (2017-2022) 49
5 DHA FROM ALGAE HISTORIC MARKET ANALYSIS BY APPLICATION 50
5.1 GLOBAL DHA FROM ALGAE SALES MARKET SHARE BY APPLICATION (2017-2022) 50
5.2 GLOBAL DHA FROM ALGAE REVENUE MARKET SHARE BY APPLICATION (2017-2022) 50
5.3 GLOBAL DHA FROM ALGAE PRICE BY APPLICATION (2017-2022) 51
6 DHA FROM ALGAE MARKET SIZE BY TYPE & BY APPLICATION 52
6.1 2021 DHA FROM ALGAE MARKET SIZE BY TYPE & BY APPLICATION (GLOBAL) (MT, US DOLLAR) 52
6.2 2021 DHA FROM ALGAE AVERAGE PRICE BY TYPE & BY APPLICATION (GLOBAL) (US DOLLAR/KG) 52
7 KEY COMPANIES PROFILED 53
7.1 DSM 53
7.1.1 DSM CORPORATION INFORMATION 53
7.1.2 DSM DESCRIPTION AND BUSINESS OVERVIEW 54
7.1.3 DSM DHA FROM ALGAE SALES, REVENUE AND GROSS MARGIN (2017-2022) 55
7.1.4 DSM DHA FROM ALGAE PRODUCT PORTFOLIO 55
7.1.5 DSM RECENT DEVELOPMENTS/UPDATES 57
7.2 ROQUETTE 58
7.2.1 ROQUETTE CORPORATION INFORMATION 58
7.2.2 ROQUETTE DESCRIPTION AND BUSINESS OVERVIEW 59
7.2.3 ROQUETTE DHA FROM ALGAE SALES, REVENUE AND GROSS MARGIN (2017-2022) 60
7.2.4 ROQUETTE DHA FROM ALGAE PRODUCT PORTFOLIO 60
7.3 CORBION 60
7.3.1 CORBION CORPORATION INFORMATION 61
7.3.2 CORBION DESCRIPTION AND BUSINESS OVERVIEW 61
7.3.3 CORBION DHA FROM ALGAE SALES, REVENUE AND GROSS MARGIN (2017-2022) 62
7.3.4 CORBION DHA FROM ALGAE PRODUCT PORTFOLIO 62
7.3.5 CORBION RECENT DEVELOPMENTS/UPDATES 63
7.4 HUISON 65
7.4.1 HUISON CORPORATION INFORMATION 65
7.4.2 HUISON DESCRIPTION AND BUSINESS OVERVIEW 65
7.4.3 HUISON DHA FROM ALGAE SALES, REVENUE AND GROSS MARGIN (2017-2022) 66
7.4.4 HUISON DHA FROM ALGAE PRODUCT PORTFOLIO 67
7.5 RUNKE 70
7.5.1 RUNKE CORPORATION INFORMATION 70
7.5.2 RUNKE DESCRIPTION AND BUSINESS OVERVIEW 71
7.5.3 RUNKE DHA FROM ALGAE SALES, REVENUE AND GROSS MARGIN (2017-2022) 71
7.5.4 RUNKE DHA FROM ALGAE PRODUCT PORTFOLIO 71
7.6 ADM 72
7.6.1 ADM CORPORATION INFORMATION 72
7.6.2 ADM DESCRIPTION AND BUSINESS OVERVIEW 73
7.6.3 ADM DHA FROM ALGAE SALES, REVENUE AND GROSS MARGIN (2017-2022) 74
7.6.4 ADM DHA FROM ALGAE PRODUCT PORTFOLIO 74
7.6.5 ADM RECENT DEVELOPMENTS/UPDATES 75
7.7 MARA RENEWABLES 76
7.7.1 MARA RENEWABLES CORPORATION INFORMATION 76
7.7.2 MARA RENEWABLES DESCRIPTION AND BUSINESS OVERVIEW 77
7.7.3 MARA RENEWABLES DHA FROM ALGAE SALES, REVENUE AND GROSS MARGIN (2017-2022) 77
7.7.4 MARA RENEWABLES DHA FROM ALGAE PRODUCT PORTFOLIO 78
7.7.5 MARA RENEWABLES RECENT DEVELOPMENTS/UPDATES 79
7.8 CABIO 79
7.8.1 CABIO CORPORATION INFORMATION 79
7.8.2 CABIO DESCRIPTION AND BUSINESS OVERVIEW 80
7.8.3 CABIO DHA FROM ALGAE SALES, REVENUE AND GROSS MARGIN (2017-2022) 81
7.8.4 CABIO DHA FROM ALGAE PRODUCT PORTFOLIO 81
7.8.5 CABIO RECENT DEVELOPMENTS/UPDATES 82
7.9 SOLUTEX 82
7.9.1 SOLUTEX CORPORATION INFORMATION 83
7.9.2 SOLUTEX DESCRIPTION AND BUSINESS OVERVIEW 83
7.9.3 SOLUTEX DHA FROM ALGAE SALES, REVENUE AND GROSS MARGIN (2017-2022) 84
7.9.4 SOLUTEX DHA FROM ALGAE PRODUCT PORTFOLIO 84
7.10 KINGDOMWAY 85
7.10.1 KINGDOMWAY CORPORATION INFORMATION 85
7.10.2 KINGDOMWAY DESCRIPTION AND BUSINESS OVERVIEW 85
7.10.3 KINGDOMWAY DHA FROM ALGAE SALES, REVENUE AND GROSS MARGIN (2017-2022) 86
7.10.4 KINGDOMWAY DHA FROM ALGAE PRODUCT PORTFOLIO 86
7.11 FERMENTALG 87
7.11.1 FERMENTALG CORPORATION INFORMATION 87
7.11.2 FERMENTALG DESCRIPTION AND BUSINESS OVERVIEW 87
7.11.3 FERMENTALG DHA FROM ALGAE SALES, REVENUE AND GROSS MARGIN (2017-2022) 88
7.11.4 FERMENTALG DHA FROM ALGAE PRODUCT PORTFOLIO 88
7.11.5 FERMENTALG RECENT DEVELOPMENTS/UPDATES 90
7.12 JC BIOTECH 90
7.12.1 JC BIOTECH CORPORATION INFORMATION 91
7.12.2 JC BIOTECH DESCRIPTION AND BUSINESS OVERVIEW 91
7.12.3 JC BIOTECH DHA FROM ALGAE SALES, REVENUE AND GROSS MARGIN (2017-2022) 92
7.12.4 JC BIOTECH DHA FROM ALGAE PRODUCT PORTFOLIO 92
7.12.5 JC BIOTECH RECENT DEVELOPMENTS/UPDATES 93
7.13 KEYUAN 94
7.13.1 KEYUAN CORPORATION INFORMATION 94
7.13.2 KEYUAN DESCRIPTION AND BUSINESS OVERVIEW 94
7.13.3 KEYUAN DHA FROM ALGAE SALES, REVENUE AND GROSS MARGIN (2017-2022) 95
7.13.4 KEYUAN DHA FROM ALGAE PRODUCT PORTFOLIO 95
7.14 BIOPLUS LIFE SCIENCES 97
7.14.1 BIOPLUS LIFE SCIENCES CORPORATION INFORMATION 97
7.14.2 BIOPLUS LIFE SCIENCES DESCRIPTION AND BUSINESS OVERVIEW 98
7.14.3 BIOPLUS LIFE SCIENCES DHA FROM ALGAE SALES, REVENUE AND GROSS MARGIN (2017-2022) 99
7.14.4 BIOPLUS LIFE SCIENCES DHA FROM ALGAE PRODUCT PORTFOLIO 99
7.14.5 BIOPLUS LIFE SCIENCES RECENT DEVELOPMENTS/UPDATES 101
7.15 FUXING 101
7.15.1 FUXING CORPORATION INFORMATION 101
7.15.2 FUXING DESCRIPTION AND BUSINESS OVERVIEW 102
7.15.3 FUXING DHA FROM ALGAE SALES, REVENUE AND GROSS MARGIN (2017-2022) 103
7.15.4 FUXING DHA FROM ALGAE PRODUCT PORTFOLIO 103
8 DHA FROM ALGAE MANUFACTURING COST ANALYSIS 104
8.1 DHA FROM ALGAE KEY RAW MATERIALS ANALYSIS 104
8.1.1 KEY RAW MATERIALS 104
8.1.2 KEY SUPPLIERS OF RAW MATERIALS 105
8.2 GLOBAL MICROALGAE MARKET ESTIMATES AND FORECASTS (2017-2028) 106
8.2.1 GLOBAL MICROALGAE MARKET SIZE IN VALUE GROWTH RATE (2017-2028) 106
8.2.2 GLOBAL MICROALGAE MARKET SIZE IN VOLUME GROWTH RATE (2017-2028) 107
8.2.3 GLOBAL MICROALGAE PRICE TRENDS (2017-2028) 108
8.2.4 GLOBAL TOP MICROALGAE PLAYERS BY SALES (2017-2022) 109
8.2.5 GLOBAL TOP MICROALGAE PLAYERS BY REVENUE (2017-2022) 110
8.2.6 GLOBAL MICROALGAE AVERAGE PRICE BY COMPANY (2017-2022) 112
8.3 PROPORTION OF MANUFACTURING COST STRUCTURE 113
8.4 MANUFACTURING PROCESS ANALYSIS OF DHA FROM ALGAE 114
8.5 DHA FROM ALGAE INDUSTRIAL CHAIN ANALYSIS 115
9 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS 116
9.1 MARKETING CHANNEL 116
9.2 DHA FROM ALGAE DISTRIBUTORS LIST 117
9.3 DHA FROM ALGAE CUSTOMERS 118
10 DHA FROM ALGAE MARKET DYNAMICS 122
10.1 DHA FROM ALGAE INDUSTRY TRENDS 122
10.2 DHA FROM ALGAE MARKET DRIVERS 123
10.3 DHA FROM ALGAE MARKET CHALLENGES 124
10.4 DHA FROM ALGAE MARKET RESTRAINTS 124
11 GLOBAL MARKET FORECAST 125
11.1 DHA FROM ALGAE MARKET ESTIMATES AND PROJECTIONS BY TYPE 125
11.1.1 GLOBAL FORECASTED SALES OF DHA FROM ALGAE BY TYPE (2023-2028) 125
11.1.2 GLOBAL FORECASTED REVENUE OF DHA FROM ALGAE BY TYPE (2023-2028) 125
11.2 DHA FROM ALGAE MARKET ESTIMATES AND PROJECTIONS BY APPLICATION 126
11.2.1 GLOBAL FORECASTED SALES OF DHA FROM ALGAE BY APPLICATION (2023-2028) 126
11.2.2 GLOBAL FORECASTED REVENUE OF DHA FROM ALGAE BY APPLICATION (2023-2028) 126
11.3 DHA FROM ALGAE MARKET ESTIMATES AND PROJECTIONS BY REGION 127
11.3.1 GLOBAL FORECASTED SALES OF DHA FROM ALGAE BY REGION (2023-2028) 127
11.3.2 GLOBAL FORECASTED REVENUE OF DHA FROM ALGAE BY REGION (2023-2028) 127
12 RESEARCH FINDINGS AND CONCLUSION 129
13 METHODOLOGY AND DATA SOURCE 130
13.1 METHODOLOGY/RESEARCH APPROACH 130
13.1.1 RESEARCH PROGRAMS/DESIGN 130
13.1.2 MARKET SIZE ESTIMATION 131
13.1.3 MARKET BREAKDOWN AND DATA TRIANGULATION 132
13.2 DATA SOURCE 133
13.2.1 SECONDARY SOURCES 133
13.2.2 PRIMARY SOURCES 134
13.3 AUTHOR LIST 136
13.4 DISCLAIMER 137
鈥
DSM
Fermentalg
JC Biotech
Bioplus Life Sciences
Roquette
ADM
Runke
Fuxing
Solutex
Mara Renewables
Kingdomway
Keyuan
Huison
Cabio
Corbion
Ìý
Ìý
*If Applicable.
